Skip to main content
IDEAYA Biosciences, Inc. logo

IDEAYA Biosciences, Inc. — Investor Relations & Filings

Ticker · IDYA ISIN · US45166A1025 LEI · 549300ULW08F62IJML11 US Manufacturing
Filings indexed 465 across all filing types
Latest filing 2023-08-12 Director's Dealing
Country US United States of America
Listing US IDYA

About IDEAYA Biosciences, Inc.

https://www.ideayabio.com/

IDEAYA Biosciences, Inc. is a clinical-stage precision medicine oncology company focused on the discovery, development, and commercialization of targeted therapeutics for cancer. The company's primary scientific approach is synthetic lethality, an emerging class of precision medicine that targets cancer cells based on specific genetic alterations. IDEAYA develops potential first-in-class and best-in-class therapies for patient populations selected using molecular diagnostics. Its integrated platform combines capabilities in target and biomarker discovery with the development of small molecule and protein degrader therapeutics to address unmet needs in cancer treatment.

Recent filings

Filing Released Lang Actions
Director's Dealing 2023
Director's Dealing
2023-08-12 English
10-Q
Interim / Quarterly Report Q2 2023
2023-08-10 English
8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated August 10, 2023, reporting the company's financial results for the second quarter ended June 30, 2023. It includes a press release as an exhibit announcing these results. The text explicitly states that the press release is furnished and not filed, and the document is relatively short (3612 characters). This matches the characteristics of an Earnings Release (ER), which is the initial announcement of quarterly financial results with key highlights. It is not a full interim report (IR) because it does not contain detailed financial statements or substantive financial data, only a press release summary. Therefore, the correct classification is Earnings Release (ER).
2023-08-10 English
Regulatory Filings 2023
Regulatory Filings
2023-08-09 English
Director's Dealing 2023
Director's Dealing
2023-07-12 English
Regulatory Filings 2023
Regulatory Filings
2023-07-10 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.